AIMLF
AI/ML Innovations Inc.·Healthcare
0.05
6.094%(−0.00)
Close PriceLast Updated: — ET
52W L: $0.0252W H: $0.09
AIMLF NEWS
accessnewswire.com
May 11
AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / May 11, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB) is pleased to announce that it has closed the second and final tranche of its previously announced non-brokered private placement (the "Offering") pursuant to which the Company has issued convertible debentures ("Debentures") in the aggregate principal amount of $1,917,500. Together with the first tranche closing, the Company has issued Debentures in the aggregate principal amount of $2,867,500.
accessnewswire.com
May 11
AIML Appoints Dr. Martin Green to Medical Advisory Board and Issue Options
Founding Architect of Canadian Cardiac Electrophysiology and 45-Year Authority on Electrocardiography Joins AIML's Medical Advisory Board TORONTO, ON / ACCESS Newswire / May 11, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the appointment of Dr. Martin Stephen Green, MD, FRCPC, Professor Emeritus at the University of Ottawa, to the Company's Medical Advisory Board (the "MAB"), effective April 27, 2026. Dr. Green joins the MAB at the invitation of Dr. Paul Dorian, MD, MSc.
accessnewswire.com
Apr 24
AI/ML Innovations Announces Completion of Share Issuance
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / April 24, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB) is pleased to announce that it has completed its previously announced share for debt issuance with certain service providers of the Company pursuant to which the Company has issued an aggregate of 17,118,420 common shares (the "Subject Shares") at a deemed price of Cdn$0.05 per Subject Share totalling Cdn$855,921 in consideration of past services and satisfaction of outstanding indebtedness (the "Debt Settlement"). The Subject Shares are subject to a statutory hold period expiring on August 25, 2026.
accessnewswire.com
Apr 17
AI/ML Innovations Announces Completion of Share Issuance
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / April 17, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB) is pleased to announce that it has completed its previously announced share for debt issuance with certain service providers of the Company pursuant to which the Company has issued an aggregate of 17,118,420 common shares (the "Subject Shares") at a deemed price of Cdn$0.05 per Subject Share in consideration of past services and satisfaction of outstanding indebtedness. The Subject Shares are subject to a statutory hold period expiring on August 18, 2026.
accessnewswire.com
Mar 31
Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform
Collaboration Expands Reach of MaxYield™ into Remote Heart Monitoring and Preventive Cardiology Applications TORONTO, ON / ACCESS Newswire / March 31, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) today announced that its wholly owned subsidiary, Neural Cloud Solutions Inc. ("Neural Cloud"), entered into a reseller agreement on March 25th, 2026 with a European-based digital health platform specializing in cloud-based ECG and heart rate variability (HRV) analytics. Under the agreement, the partner platform will integrate and resell Neural Cloud's MaxYield™ ECG signal-processing technology to its customers as either a standalone capability or as part of a bundled remote cardiac monitoring solution.
accessnewswire.com
Mar 27
AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / March 27, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB) is pleased to announce that it has closed the first tranche of its previously announced non-brokered private placement (the "Offering") pursuant to which the Company has issued convertible debentures ("Debentures") in the aggregate principal amount of $950,000. The Debentures may be converted into units of the Company ("Units") at the option of the holder of the Debentures at any time at a conversion price of $0.05 per Unit, with each Unit being comprised of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant").
